AngioDynamics reported $285.41M in Assets for its fiscal quarter ending in February of 2025.





Assets Change Date
AngioDynamics USD 285.41M 6.14M Feb/2025
AtriCure USD 635.44M 26.59M Sep/2025
Boston Scientific USD 42.71B 1.15B Sep/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
ICU Medical USD 4.1B 4.49M Sep/2025
Inogen USD 307.01M 5.03M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Medtronic USD 90.97B 708M Jun/2025
Merit Medical Systems USD 2.63B 44.95M Sep/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 832.61M 4.55M Sep/2025
Smiths GBP 4.29B 226M Dec/2025
Surmodics USD 178.56M 1.15M Sep/2024
Tandem Diabetes Care USD 874.65M 1.08M Sep/2025
Teleflex USD 7.87B 496.72M Sep/2025
Terumo JPY 1.89T 95.38B Sep/2025
Trinity Biotech USD 103.71M 4.08M Sep/2025